ITMCTR2200006759
Not yet recruiting
未知
Standardized study on the diagnosis and treatment plan of non-alcoholic fatty liver disease treated with the method of clearing phlegm and dampness
onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 sitesTBD
Conditionsonalcoholic Fatty Liver Disease
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- onalcoholic Fatty Liver Disease
- Sponsor
- onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Age 18 to 75 years;
- •2\.Patients who meet the above western medical diagnostic criteria and the wet turbidity internal stop certificate;
- •3\.Patients who are willing to sign informed consent.
- •4\.Serum alanine aminotransferase (ALT) \= 2 times the upper limit of normal, total bilirubin (TBIL) \= 2 times the upper limit of normal
Exclusion Criteria
- •1\. Patients with fatty liver, Reye syndrome fatty liver, ß\-lipoprotein deficiency and localized fatty liver caused by chronic heart failure, malnutrition and pregnancy. Patients with fatty liver caused by diabetes, long\-term use of hormones, small intestinal bypass surgery, toxic injury to liver cells, chronic febrile diseases such as tuberculosis, ulcerative colitis, and chronic infection after gastrointestinal surgery.
- •2\. Severe fatty liver with ascites, edema, hyponatremia, hypokalemia and other suspected manifestations of liver cirrhosis; hepatitis or cirrhosis caused by virus, drug poisoning, immune diseases and other factors.
- •3\. Other Chinese and Western medicines for the treatment of simple fatty liver have been used after this onset.
- •4\. Patients who have serious primary cardiovascular disease, liver disease, kidney disease, hematological disease, lung disease, or serious diseases that affect their survival, such as tumor or AIDS.
- •5\. Mentally or legally disabled patients.
- •6\. Suspected or indeed have a history of alcohol or drug abuse, or other diseases that reduce the possibility of enrollment or complicate enrollment according to the judgment of the investigator, such as frequent changes in the working environment, which are likely to cause loss to follow\-up.
- •7\. Those who are known to be allergic to the components of this medicine.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
STANDARD-Study -- Standardized Treatment and Diagnostic Approach to Reduce Disease burden in the early post-operative phase in children with congenital heart defectsQ20-Q28Congenital malformations of the circulatory systemDRKS00025430niversitätsklinikum des Saarlandes74
Not yet recruiting
Phase 1
Clinical study on precise diagnosis and treatment of refractory gastroesophageal reflux disease by Traditional Chinese medicine based on intestinal microecological macroomics technologyITMCTR2000003951Shanghai Traditional Chinese Medicine Hospital
Not yet recruiting
Phase 1
Clinical study on precise Diagnosis and treatment of vocal cord leukoplakia by Chinese and Western medicinevocal leukoplakiaITMCTR2000003989Shanghai Municipal Hospital of Traditional Chinese Medicine
Not yet recruiting
Phase 1
Clinical study on the precise diagnosis and treatment of nonalcoholic fatty liver disease with Trinity therapy combined with fibrotouth TechnologyITMCTR2000004000Shanghai Hospital of Traditional Chinese Medicine
Completed
Phase 1
The clinical standardization study on the treatment of spleen deficiency syndrome after repeated respiratory tract infection by the method of cultivating earth to generate goldSpleen deficiency syndrome after recurrent respiratory tract infection in childrenITMCTR2100004923Children's Hospital of Shanghai